Role of thymoquinone in treatment of pancreatic cancer
10.3969/j.issn.1001-5256.2023.05.036
- VernacularTitle:百里醌在胰腺癌治疗中的作用
- Author:
Zhanxue ZHAO
1
,
2
;
Linxun LIU
2
;
Shuai LI
3
;
Xiaofan HOU
4
;
Jinyu YANG
2
Author Information
1. Medical College of Soochow University, Suzhou, Jiangsu 215123, China
2. Department of General Surgery, Qinghai Provincial People's Hospital, Xining 810007, China
3. Department of Clinical Pharmacy, The Affiliated Hospital of Qinghai University, Xining 810001, China
4. Graduate School of Qinghai University, Xining 810016, China
- Publication Type:Review
- Keywords:
Pancreatic Neoplasms;
Thymoquinone;
Therapeutics
- From:
Journal of Clinical Hepatology
2023;39(5):1234-1244
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is one of the cancers with the worst prognosis, and its high metastasis rate and resistance to chemotherapy drugs have always been the tough problems in the medical field. At present, the effect of thymoquinone on pancreatic cancer has attracted wide attention, and it can exert an antitumor effect in pancreatic cancer by inhibiting cancer cell proliferation, promoting cancer cell apoptosis, inhibiting invasion and metastasis, enhancing the sensitivity to chemotherapy drugs, and exerting an anti-inflammatory effect. This review briefly introduces the current research status of the association between thymoquinone and pancreatic cancer in China and globally, so as to provide a reference for subsequent research.
